T-cell–T-cell interactions such as CD8+ T cell-Th17 and CD8+ T cell-Treg could regulate the cytotoxic function of T cells, further impacting the anti-tumor efficacy of immunotherapy. This evidence concerns the gene CD8A and neoplasm.